Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|July 15, 2020
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patientsBei Hu, Xiao Lin, Hans C Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 24, 2018
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR AnalysisWilliam A Wood, Ruta Brazauskas, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 29, 2018
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Ying Liu, Michael T Hemmer, et al.
Haematologica|February 13, 2023
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosisGuru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2016
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple MyelomaRobert F Cornell, Anita D'Souza, Adetola A Kassim, et al.
Blood|July 5, 2017
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, Marcelo C Pasquini, Michael Martens, et al.
Transplantation and Cellular Therapy|August 17, 2021
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic SyndromesBetül Oran, Kwang Woo Ahn, Caitrin Fretham, et al.
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2019
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant ResearchDavid Buchbinder, Ruta Brazauskas, Khalid Bo-Subait, et al.
Transplantation and Cellular Therapy|August 24, 2021
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in AdultsLeland Metheny, Natalie S Callander, Aric C Hall, et al.
Pageof 14